Literature DB >> 14551176

Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics.

Donald E Mager1, Sheren X Lin, Robert A Blum, Christian D Lates, William J Jusko.   

Abstract

The integrity of current corticosteroid dose equivalency tables, as assessed by mechanistic models for cell trafficking and cortisol dynamics, was investigated in this study. Single, presumably equivalent, doses of intravenous hydrocortisone, methylprednisolone, dexamethasone, and oral prednisolone were given to 5 white men, according to total body weight, in a 5-way crossover, placebo-controlled study. Pharmacodynamic (PD) response-time profiles for T helper cells, T suppressor cells, neutrophils, and adrenal suppression were evaluated by extended indirect response models. For adrenal suppression, prednisolone appears to be less potent than methylprednisolone or dexamethasone. A good correlation was found between the estimated in vivo EC50 values and relative receptor affinity (equilibrium dissociation constants normalized to dexamethasone). Area under the effect curves of all PD responses was calculated using a linear-trapezoidal method. Although T helper cell trafficking and adrenal suppression achieved significant differences by repeated-measures ANOVA (p = 0.014 and 0.022), post hoc analysis using the Bonferroni method revealed no difference between treatments. Although limited by the use of single doses and a relatively small sample size, this study applies mechanistic models for several biomarkers showing that currently used dosing tables reflect reasonable dose equivalency relationships for four corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551176     DOI: 10.1177/0091270003258651

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  54 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Inhibition of chlorine-induced pulmonary inflammation and edema by mometasone and budesonide.

Authors:  Jing Chen; Yiqun Mo; Connie F Schlueter; Gary W Hoyle
Journal:  Toxicol Appl Pharmacol       Date:  2013-06-22       Impact factor: 4.219

3.  Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liver.

Authors:  Vivaswath S Ayyar; Siddharth Sukumaran; Debra C DuBois; Richard R Almon; Jun Qu; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-04-27       Impact factor: 2.745

4.  Evaluation of Systemic Corticosteroids in Patients With an Acute Exacerbation of COPD and a Diagnosis of Pneumonia.

Authors:  Tyler Scholl; Tyree H Kiser; Sheryl F Vondracek
Journal:  Chronic Obstr Pulm Dis       Date:  2018-01-24

5.  Biphasic and protracted anaphylaxis to iodinated contrast media.

Authors:  Tae-Hyung Kim; Soon Ho Yoon; Suh-Young Lee; Young Hun Choi; Chang Min Park; Hye-Ryun Kang; Sang-Heon Cho
Journal:  Eur Radiol       Date:  2017-09-27       Impact factor: 5.315

6.  Modeling the Effect of the Selective S1P1 Receptor Modulator Ponesimod on Subsets of Blood Lymphocytes.

Authors:  Dominik Lott; Andreas Krause; Christian A Seemayer; Daniel S Strasser; Jasper Dingemanse; Thorsten Lehr
Journal:  Pharm Res       Date:  2016-12-27       Impact factor: 4.200

Review 7.  Pharmacokinetic/pharmacodynamic modeling in inflammation.

Authors:  Hoi-Kei Lon; Dongyang Liu; William J Jusko
Journal:  Crit Rev Biomed Eng       Date:  2012

8.  The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro.

Authors:  Mario Presti; Marie Christine Wulff Westergaard; Arianna Draghi; Christopher Aled Chamberlain; Aishwarya Gokuldass; Inge Marie Svane; Marco Donia
Journal:  Cancer Immunol Immunother       Date:  2020-11-09       Impact factor: 6.968

9.  Pharmacokinetic/pharmacodynamic modeling of corticosterone suppression and lymphocytopenia by methylprednisolone in rats.

Authors:  Zhenling Yao; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

10.  Assessment of the impact of dosing time on the pharmacokinetics/pharmacodynamics of prednisolone.

Authors:  Jian Xu; Julia Winkler; Sreedharan Nair Sabarinath; Hartmut Derendorf
Journal:  AAPS J       Date:  2008-06-25       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.